Real-time Research as Cases Climb

Reports of new Ebola cases in the Democratic Republic of the Congo keep climbing, but the focus isn’t just on treating the sick—it’s also on transforming the treatment.
 
Despite the difficulty of working in the conflict-plagued country, researchers are deploying 4 experimental drugs, Sarah Boseley reports in the Guardian. If successful, the new treatments could transform Ebola into a disease that can be treated at home rather than in isolation units. "You could turn Ebola from something that really is feared and horrific in communities to something that is preventable and treatable,” says Wellcome Trust Director Jeremy Farrar.

As of yesterday, DRC’s case count was up to 444, CIDRAP reported, while Médecins Sans Frontières expressed particular concern over the virus’s spread to Butembo. After the US CDC's withdrawal, medical experts appealed for their return last week but WHO Director-General Tedros Adhanom Ghebreyesus said the WHO can cover the fight—though US financial assistance is still needed. (ICYMI: See this JAMA commentary.)

Comments +

0 comments

Post a Comment

Restricted HTML

  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Back to top